Modeling Dabrafenib Response Using Multi-Omics Modality Fusion and Protein Network Embeddings Based on Graph Convolutional Networks

• URL: http://arxiv.org/abs/2512.12134v1
• Date: Sat, 13 Dec 2025 02:00:56 GMT
• Title: Modeling Dabrafenib Response Using Multi-Omics Modality Fusion and Protein Network Embeddings Based on Graph Convolutional Networks
• Authors: La Ode Aman, A Mu'thi Andy Suryadi, Dizky Ramadani Putri Papeo, Hamsidar Hasan, Ariani H Hutuba, Netty Ino Ischak, Yuszda K. Salimi,
• Abstract summary: Cancer cell response to targeted therapy arises from complex molecular interactions, making single omics insufficient for accurate prediction.<n>This study develops a model to predict Dabrafenib sensitivity by integrating multiple omics layers (genomics, transcriptomics, epigenomics, metabolomics) with protein network embeddings generated using Graph Convolutional Networks (GCN)<n>Results show that attention guided multi omics fusion combined with GCN improves drug response prediction and reveals complementary molecular determinants of Dabrafenib sensitivity.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Cancer cell response to targeted therapy arises from complex molecular interactions, making single omics insufficient for accurate prediction. This study develops a model to predict Dabrafenib sensitivity by integrating multiple omics layers (genomics, transcriptomics, proteomics, epigenomics, and metabolomics) with protein network embeddings generated using Graph Convolutional Networks (GCN). Each modality is encoded into low dimensional representations through neural network preprocessing. Protein interaction information from STRING is incorporated using GCN to capture biological topology. An attention based fusion mechanism assigns adaptive weights to each modality according to its relevance. Using GDSC cancer cell line data, the model shows that selective integration of two modalities, especially proteomics and transcriptomics, achieves the best test performance (R2 around 0.96), outperforming all single omics and full multimodal settings. Genomic and epigenomic data were less informative, while proteomic and transcriptomic layers provided stronger phenotypic signals related to MAPK inhibitor activity. These results show that attention guided multi omics fusion combined with GCN improves drug response prediction and reveals complementary molecular determinants of Dabrafenib sensitivity. The approach offers a promising computational framework for precision oncology and predictive modeling of targeted therapies.

Related papers

• R-GenIMA: Integrating Neuroimaging and Genetics with Interpretable Multimodal AI for Alzheimer's Disease Progression [63.97617759805451]
  Early detection of Alzheimer's disease requires models capable of integrating macro-scale neuroanatomical alterations with micro-scale genetic susceptibility.<n>We introduce R-GenIMA, an interpretable multimodal large language model that couples a novel ROI-wise vision transformer with genetic prompting.<n>R-GenIMA achieves state-of-the-art performance in four-way classification across normal cognition, subjective memory concerns, mild cognitive impairment, and AD.
  arXiv  Detail & Related papers  (2025-12-22T02:54:10Z)
• GastroDL-Fusion: A Dual-Modal Deep Learning Framework Integrating Protein-Ligand Complexes and Gene Sequences for Gastrointestinal Disease Drug Discovery [2.1880525779004563]
  GastroDL-Fusion is a dual-modal deep learning framework that integrates protein-ligand complex data with disease-associated gene sequence information.<n>We evaluate the model on benchmark datasets of GI disease-related targets.<n>Results confirm that incorporating both structural and genetic features yields more accurate predictions of binding affinities.
  arXiv  Detail & Related papers  (2025-11-07T21:32:58Z)
• KEPLA: A Knowledge-Enhanced Deep Learning Framework for Accurate Protein-Ligand Binding Affinity Prediction [60.23701115249195]
  KEPLA is a novel deep learning framework that integrates prior knowledge from Gene Ontology and ligand properties to enhance prediction performance.<n> Experiments on two benchmark datasets demonstrate that KEPLA consistently outperforms state-of-the-art baselines.
  arXiv  Detail & Related papers  (2025-06-16T08:02:42Z)
• Interpretable Graph Kolmogorov-Arnold Networks for Multi-Cancer Classification and Biomarker Identification using Multi-Omics Data [36.92842246372894]
  Multi-Omics Graph Kolmogorov-Arnold Network (MOGKAN) is a deep learning framework that utilizes messenger-RNA, micro-RNA sequences, and DNA methylation samples.<n>By integrating multi-omics data with graph-based deep learning, our proposed approach demonstrates robust predictive performance and interpretability.
  arXiv  Detail & Related papers  (2025-03-29T02:14:05Z)
• scMamba: A Pre-Trained Model for Single-Nucleus RNA Sequencing Analysis in Neurodegenerative Disorders [43.24785083027205]
  scMamba is a pre-trained model designed to improve the quality and utility of snRNA-seq analysis.<n>Inspired by the recent Mamba model, scMamba introduces a novel architecture that incorporates a linear adapter layer, gene embeddings, and bidirectional Mamba blocks.<n>We demonstrate that scMamba outperforms benchmark methods in various downstream tasks, including cell type annotation, doublet detection, imputation, and the identification of differentially expressed genes.
  arXiv  Detail & Related papers  (2025-02-12T11:48:22Z)
• SFM-Protein: Integrative Co-evolutionary Pre-training for Advanced Protein Sequence Representation [97.99658944212675]
  We introduce a novel pre-training strategy for protein foundation models. It emphasizes the interactions among amino acid residues to enhance the extraction of both short-range and long-range co-evolutionary features. Trained on a large-scale protein sequence dataset, our model demonstrates superior generalization ability.
  arXiv  Detail & Related papers  (2024-10-31T15:22:03Z)
• Binding Affinity Prediction: From Conventional to Machine Learning-Based Approaches [48.66541987908136]
  Much work has been devoted to predicting binding affinity over the past decades.<n>We note growing use of both traditional machine learning and deep learning models for predicting binding affinity.<n>With improved predictive performance and the FDA's phasing out of animal testing, AI-driven in silico models, such as AI virtual cells (AIVCs), are poised to advance binding affinity prediction.
  arXiv  Detail & Related papers  (2024-09-30T03:40:49Z)
• LASSO-MOGAT: A Multi-Omics Graph Attention Framework for Cancer Classification [41.94295877935867]
  This paper introduces LASSO-MOGAT, a graph-based deep learning framework that integrates messenger RNA, microRNA, and DNA methylation data to classify 31 cancer types.
  arXiv  Detail & Related papers  (2024-08-30T16:26:04Z)
• Improved K-mer Based Prediction of Protein-Protein Interactions With Chaos Game Representation, Deep Learning and Reduced Representation Bias [0.0]
  We present a method for extracting unique pairs from an interaction dataset, generating non-redundant paired data for unbiased machine learning. We develop a convolutional neural network model capable of learning and predicting interactions from Chaos Game Representations of proteins' coding genes.
  arXiv  Detail & Related papers  (2023-10-23T10:02:23Z)
• State-specific protein-ligand complex structure prediction with a multi-scale deep generative model [68.28309982199902]
  We present NeuralPLexer, a computational approach that can directly predict protein-ligand complex structures. Our study suggests that a data-driven approach can capture the structural cooperativity between proteins and small molecules, showing promise in accelerating the design of enzymes, drug molecules, and beyond.
  arXiv  Detail & Related papers  (2022-09-30T01:46:38Z)
• Learning Geometrically Disentangled Representations of Protein Folding Simulations [72.03095377508856]
  This work focuses on learning a generative neural network on a structural ensemble of a drug-target protein. Model tasks involve characterizing the distinct structural fluctuations of the protein bound to various drug molecules. Results show that our geometric learning-based method enjoys both accuracy and efficiency for generating complex structural variations.
  arXiv  Detail & Related papers  (2022-05-20T19:38:00Z)
• MOOMIN: Deep Molecular Omics Network for Anti-Cancer Drug Combination Therapy [2.446672595462589]
  We propose a multimodal graph neural network that can predict the synergistic effect of drug combinations for cancer treatment. Our model captures the representation based on the context of drugs at multiple scales based on a drug-protein interaction network and metadata. We demonstrate that the model makes high-quality predictions over a wide range of cancer cell line tissues.
  arXiv  Detail & Related papers  (2021-10-28T13:10:25Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.